|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0010181,
umls-concept:C0026336,
umls-concept:C0027051,
umls-concept:C0070166,
umls-concept:C0239307,
umls-concept:C0486588,
umls-concept:C0702240,
umls-concept:C1171947,
umls-concept:C1527178,
umls-concept:C1705938
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-8-13
|
|
pubmed:abstractText |
Several health economic studies have shown that the use of clopidogrel is cost-effective to prevent ischemic events in non-ST-segment elevation myocardial infarction (NSTEMI) and unstable angina.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0149-2918
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1184-202
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:17692733-Aged,
pubmed-meshheading:17692733-Cohort Studies,
pubmed-meshheading:17692733-Cost-Benefit Analysis,
pubmed-meshheading:17692733-Decision Support Techniques,
pubmed-meshheading:17692733-Drug Utilization Review,
pubmed-meshheading:17692733-Female,
pubmed-meshheading:17692733-France,
pubmed-meshheading:17692733-Germany,
pubmed-meshheading:17692733-Humans,
pubmed-meshheading:17692733-Male,
pubmed-meshheading:17692733-Markov Chains,
pubmed-meshheading:17692733-Middle Aged,
pubmed-meshheading:17692733-Myocardial Infarction,
pubmed-meshheading:17692733-Platelet Aggregation Inhibitors,
pubmed-meshheading:17692733-Quality-Adjusted Life Years,
pubmed-meshheading:17692733-Randomized Controlled Trials as Topic,
pubmed-meshheading:17692733-Survival Analysis,
pubmed-meshheading:17692733-Sweden,
pubmed-meshheading:17692733-Ticlopidine,
pubmed-meshheading:17692733-Time Factors,
pubmed-meshheading:17692733-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: a European model based on the CLARITY and COMMIT trials.
|
|
pubmed:affiliation |
European Health Economics, Stockholm, Sweden. jenny.b@healtheconomics.se
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
